Jan Hillson - Concepedia

Author

Jan Hillson

Also Known As

Hillson, Jan, J Hillson, J L Hillson, J. Hillson, J.L. Hillson, JAN L. HILLSON, Jan Hillson, Jan L Hillson, Jan L. Hillson, Jan Leslie Hillson

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

University of Washington Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)ChemoCentryx (United States)Momenta Pharmaceuticals (United States)

About

Jan Hillson is an author at University of Washington specializing in medicine, immunology, and immune system.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	876
2	Allergy	3	3	369
3	Natural Sciences	2	2	301
4	Public Health	1	1	10
5	Biology	1	1	176

Jan Hillson

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Early Restriction of the Human Antibody Repertoire Harry W. Schroeder, Jan Hillson, Roger M. Perlmutter Science	1987	542
Efficacy and Safety of Abatacept in Lupus Nephritis: A Twelve‐Month, Randomized, Double‐Blind Study Richard Furie, Kathy Nicholls, Tien‐Tsai Cheng, Arthritis & Rheumatology	2013	329
Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial Ellen M. Ginzler, Stephen Wax, Anand Rajeswaran, Arthritis Research & Therapy	2012	278
An unbiased analysis of V(H)-D-J(H) sequences from B-1a, B-1b, and conventional B cells Aaron B. Kantor, Cynthia Merrill, L A Herzenberg, The Journal of Immunology	1997	207
Structure and evolution of mammalian V<sub>H</sub> families Harry W. Schroeder, Jan Hillson, Roger M. Perlmutter International Immunology GeneticsGenomic MechanismMolecular BiologyGermline Gene SegmentsGenomics	1990	176
Abatacept for lupus nephritis: Alternative definitions of complete response support conflicting conclusions David Wofsy, Jan Hillson, Betty Diamond Arthritis & Rheumatism	2012	155
A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection Andrew J. Muir, Sanjeev Arora, Gregory T. Everson, Journal of Hepatology Viral PersistenceViral HepatitisAntiviral TherapyHepatitisVirology	2014	142
M281, an Anti‐FcRn Antibody: Pharmacodynamics, Pharmacokinetics, and Safety Across the Full Range of IgG Reduction in a First‐in‐Human Study Leona Ling, Jan Hillson, Renger G. Tiessen, Clinical Pharmacology & Therapeutics Clinical ImmunologyImmunohematologyImmunodeficienciesImmunologyImmunodominance	2018	140
The structural basis of germline-encoded VH3 immunoglobulin binding to staphylococcal protein A. Jan Hillson, N S Karr, I R Oppliger, The Journal of Experimental Medicine Protein AssemblyImmunologyMolecular BiologyImmunodominanceAntigen Processing	1993	125
Molecular basis of an autoantibody-associated restriction fragment length polymorphism that confers susceptibility to autoimmune diseases. T Olee, Pei–Ming Yang, K A Siminovitch, Journal of Clinical Investigation Disease EtiologyGeneticsImmunologyPathologyImmune System	1991	104

Page 1